NSW Increases Penalties and Enforcement for Illegal Vape Supply

Nov.19.2024
NSW Increases Penalties and Enforcement for Illegal Vape Supply
The New South Wales Government in Australia has introduced tougher penalties and enforcement measures for illegal vape supply, increasing fines to A$1.54 million and prison terms to seven years.

On November 19, the New South Wales (NSW) Government announced plans to raise the maximum fine for illegal vape supply from A$1,650 to approximately A$1.54 million, with prison sentences increasing from six months to seven years.

 

The NSW Government has introduced the legislation in Parliament, aiming to align state enforcement powers with those of federal agencies. Possession of a commercial quantity of vaping products or retailer possession of vapes will also be classified as illegal.

 

Similar to the Commonwealth vaping reforms, these measures target suppliers of vape products rather than individual users. Over the past year, more than 300,000 vape products have been seized by the government.

 

Between July 1 and September 30, 2024, a total of 362 inspections were conducted, resulting in the seizure of 42,000 products. In comparison, 153,000 products were confiscated from 290 inspections last year. The recent decrease in seizures during the last quarter may reflect market supply disruptions following the implementation of new Commonwealth vaping laws.

 

In October, the NSW Government announced plans to recruit 14 additional enforcement officers to enhance compliance efforts for vaping and tobacco products statewide. 

 

Additionally, they also launched the eCigarette Compliance Program, initially aimed at supporting pharmacists. A dedicated team of compliance officers will visit pharmacies across the state to provide on-site education and guidance.

 

"The prevalence of illegal vaping devices in our community, and in particular among our young people, is deeply concerning. We have a once-in-a-generation opportunity to the stem the tide of this public health challenge," said Ryan Park, the state Minister for Health, 

 

"I am very encouraged by the progress we are making in terms of removing these harmful devices from our streets. And I am pleased to announce that we are augmenting our efforts by introducing harsher penalties to target suppliers."

 

 

Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
According to Haypp’s 2026 UK Nicotine Report, nicotine pouches are increasingly replacing both cigarettes and vaping. The UK market grew sharply, with Haypp and Northerner reporting a 60% year‑on‑year sales increase in 2025. Notably, 40% of users adopted pouches to quit vaping, nearly matching the 43% who used them to stop smoking. This indicates pouches are expanding beyond traditional smoking cessation and gaining traction among adults seeking non‑inhalable nicotine alternatives.
Jul.01
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Changing Assumptions in U.S. Cigar Consumption: 2Firsts Interviews Cigar Educator Mechelle Merkerson
Changing Assumptions in U.S. Cigar Consumption: 2Firsts Interviews Cigar Educator Mechelle Merkerson
U.S. premium cigar culture is shifting toward education, broader choice and deeper links to craftsmanship and origin, cigar educator Mechelle Merkerson told 2Firsts. She sees boutique brands, women consumers and production-region experiences making knowledge central to cigar participation. For global brands, retailers and emerging markets such as China, education may help turn curiosity into sustained engagement.
Special Report
Jul.06
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12